-+ 0.00%
-+ 0.00%
-+ 0.00%

Top 3 Health Care Stocks That Could Blast Off This Month

Benzinga·01/21/2026 11:41:51
Listen to the news

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.

Here's the latest list of major oversold players in this sector, having an RSI near or below 30.

Travere Therapeutics Inc (NASDAQ:TVTX)

  • On Jan. 13, the U.S. Food and Drug Administration (FDA) extended the review timeline of Travere Therapeutics' supplemental New Drug Application (sNDA) for Filspari (sparsentan) in focal segmental glomerulosclerosis (FSGS). The new Prescription Drug User Fee Act (PDUFA) target action date is April 13. The company's stock fell around 23% over the past month and has a 52-week low of $12.91.
  • RSI Value: 29.7
  • TVTX Price Action: Shares of Travere Therapeutics rose 0.3% to close at $27.94 on Tuesday.
  • Edge Stock Ratings: 91.85 Momentum score.

Hims & Hers Health Inc (NYSE:HIMS)  

  • On Jan. 12, Evercore ISI Group analyst Mark Mahaney initiated coverage on Hims & Hers Health with an In-Line rating and announced a price target of $33. The company's stock fell around 13% over the past month and has a 52-week low of $23.97.
  • RSI Value: 29.7                         
  • HIMS Price Action: Shares of Hims & Hers Health fell 2.9% to close at $30.47 on Tuesday.
  • Benzinga Pro’s charting tool helped identify the trend in HIMS stock.

Enovis Corp (NYSE:ENOV)

  • On Jan. 6, BTIG analyst Ryan Zimmerman initiated coverage on Enovis with a Buy rating and announced a price target of $41. The company's stock fell around 14% over the past five days and has a 52-week low of $22.98.
  • RSI Value: 29.6
  • ENOV Price Action: Shares of Enovis dipped 3.7% to close at $23.09 on Tuesday.
  • Benzinga Pro’s signals feature notified of a potential breakout in ENOV shares.

Learn more about BZ Edge Rankings—click to see scores for other stocks in the sector and see how they compare.

Photo via Shutterstock